| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/28/2000 | EP1012177A1 Estrogen receptor |
| 06/28/2000 | EP1012176A1 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens |
| 06/28/2000 | EP1012175A1 A peptide with an affinity for clotting factor viii |
| 06/28/2000 | EP1012174A1 Nik proteins, nucleic acids and methods |
| 06/28/2000 | EP1012171A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof |
| 06/28/2000 | EP1012163A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 06/28/2000 | EP1012162A4 Soluble proteins |
| 06/28/2000 | EP1012162A1 Soluble proteins |
| 06/28/2000 | EP1012160A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
| 06/28/2000 | EP1012158A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
| 06/28/2000 | EP1012157A1 $i(BORRELIA BURGDORFERI) POLYNUCLEOTIDES AND SEQUENCES |
| 06/28/2000 | EP1012155A1 Human uncoupling protein 3 |
| 06/28/2000 | EP1011736A2 Polymers |
| 06/28/2000 | EP1011724A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor |
| 06/28/2000 | EP1011723A1 88kda tumorigenic growth factor and antagonists |
| 06/28/2000 | EP1011720A2 Mucosal cytotoxic t lymphocyte responses |
| 06/28/2000 | EP1011716A4 Neuromedin b receptor antagonists |
| 06/28/2000 | EP1011716A1 Neuromedin b receptor antagonists |
| 06/28/2000 | EP1011708A1 Anti-peptide antibody against human cytochrome p450 3a4 |
| 06/28/2000 | EP1011707A1 HIV-1 gp120 V1/V2 DOMAIN EPITOPES CAPABLE OF GENERATING NEUTRALIZING ANTIBODIES |
| 06/28/2000 | EP1011704A1 Tumor necrosis factor receptor-derived peptide analogues |
| 06/28/2000 | EP1011330A1 Central nervous system axon regeneration |
| 06/28/2000 | EP1011328A1 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity |
| 06/28/2000 | EP1011319A1 A method of treatment and an animal model useful for same |
| 06/28/2000 | EP0866719B1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/28/2000 | EP0820468B1 Process for the purification of glycoproteins like erythropoietin |
| 06/28/2000 | EP0811058B1 A process for the preparation of factor ix from biological sources |
| 06/28/2000 | EP0639224B1 Lectin domain variants of selectin |
| 06/28/2000 | EP0557418B1 A beta-type transforming growth factor |
| 06/28/2000 | CN1258319A Vector |
| 06/28/2000 | CN1258317A Process for expression of genes of dengue viruses |
| 06/28/2000 | CN1258316A Plant transformation methods |
| 06/28/2000 | CN1258315A Mammalian cytokine-like factor-7 |
| 06/28/2000 | CN1257927A Human protein and its coding sequence, preparing process and usage |
| 06/28/2000 | CN1257926A Human protein and its coding sequence, preparing process and usage |
| 06/28/2000 | CN1257924A Human Ras correlative GTP bindin kinase |
| 06/28/2000 | CN1257923A RaL GTP guanine dissociation stimulator |
| 06/28/2000 | CN1257922A Cytokine signal transfer arrestin IV |
| 06/28/2000 | CN1257919A Hepatitis B virus protein bound arrestin |
| 06/28/2000 | CN1257872A Leptospiral vaccine antigen for preventing leptospirosis |
| 06/28/2000 | CN1053964C Immunochemical detection of in vivo advanced glycosylation endproducts |
| 06/28/2000 | CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition |
| 06/27/2000 | USRE36755 DNA encoding tumor necrosis factor-α and -β receptors |
| 06/27/2000 | US6080914 Strawberry promoters and genes |
| 06/27/2000 | US6080913 Binary methods of increasing accumulation of essential amino acids in seeds |
| 06/27/2000 | US6080912 Methods for creating transgenic animals |
| 06/27/2000 | US6080911 Mice models of growth hormone insensitivity |
| 06/27/2000 | US6080850 Nucleotide sequence of s gene with modified major enhancing epitopes; for vaccines without accelerated progression of disease |
| 06/27/2000 | US6080849 Mutant salmonella species with a genetically engineered msbb gene, expresses altered lipid a, has reduced induction of tumor necrosis factor and increased sensitivity to chelating agents; for agents against solid tumors |
| 06/27/2000 | US6080848 Human brain associated protein |
| 06/27/2000 | US6080847 Amino acid and nucleotide sequences; for diagnosis, prevention and treatment of abnormal cell proliferative and apoptosis disorders; antiproliferative/anticarcinogenic agents; antiinflammatory agents |
| 06/27/2000 | US6080846 Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus |
| 06/27/2000 | US6080844 Process for the recovery and purification of a recombinant protein from a cell |
| 06/27/2000 | US6080842 Amino acid sequence; for anticarcinogenic/antitumor agents and treatment of nervous system disorders such as alzheimer's/parkinson's/huntington's diseases; antiepileptic agents; cognition activators; antidepressants |
| 06/27/2000 | US6080841 Human induced tumor protein |
| 06/27/2000 | US6080840 Soluble T cell receptors |
| 06/27/2000 | US6080838 Peptidomimetic of helix-turn-helix or gamma-turn |
| 06/27/2000 | US6080837 Synthesis of VIP analog |
| 06/27/2000 | US6080729 Polypeptides and polynucleotides used to screen for antibacterial compounds |
| 06/27/2000 | US6080728 Inhibiting tumor growth |
| 06/27/2000 | US6080724 Peptides which can be used as vectors for the intracellular addressing of active molecules |
| 06/27/2000 | US6080722 Methods for utilizing such polynucleotides or polypeptides as a diagnostic marker for colon cancer and as an agent to determine if colon cancer has metastasized |
| 06/27/2000 | US6080721 Pulmonary delivery of active fragments of parathyroid hormone |
| 06/27/2000 | US6080718 Useful in the identification and isolation of components involved in transmembrane receptor-mediated signaling |
| 06/27/2000 | US6080582 Cell tests for Alzheimer's disease |
| 06/27/2000 | US6080578 Cytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasia |
| 06/27/2000 | US6080577 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy |
| 06/27/2000 | US6080571 Highly efficient production and isolation of viral particles utilizing tentacle anion exchange |
| 06/27/2000 | US6080560 Method for producing antibodies in plant cells |
| 06/27/2000 | US6080559 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus |
| 06/27/2000 | US6080558 Polynucleotide encoding human growth regulator protein |
| 06/27/2000 | US6080556 Dna coding for specific amino acid sequences; for detection of gene in samples using polymerase chain reaction |
| 06/27/2000 | US6080550 Isolation and characterization of Agouti: a diabetes/obesity related gene |
| 06/27/2000 | US6080542 Plant peptide transport gene |
| 06/27/2000 | US6080540 Expressing mammalian gene in a recombinant microorganism causing modified phenotype associated with mutation, incubating with chemical, determining if altered phenotype is reversed indicating that agent suppresses the mammalian gene |
| 06/27/2000 | US6080409 Immunostimulatory method |
| 06/27/2000 | US6080408 Particles contain mutations to reduce gag-dependent rna-packaging of the gag gene product, eliminate reverse transcriptase, integrase activity and rnase h activity of the pol gene product through genetic manipulation; vaccines; aids |
| 06/27/2000 | US6080407 Diagnostic assays for MIF |
| 06/27/2000 | US6080406 Hematopoietic cytokine receptor |
| 06/27/2000 | US6080405 Foam proteins and use thereof |
| 06/27/2000 | US6080400 Compositions for the prevention and treatment of verotoxin-induced disease |
| 06/27/2000 | US6080398 Chemokines modified by truncation of from 2 to 8 amino acids from the amino terminus of the corresponding mature chemokine selected from kc, gro-beta, gro-gamma, and gro-alpha; lower dose needed, less toxicity |
| 06/27/2000 | CA2134083C Prophylactic and therapeutic agents for autoimmune diseases |
| 06/27/2000 | CA2089553C Multidomain hematopoiesis stimulators |
| 06/27/2000 | CA2076744C Viral agent associated with mystery swine disease |
| 06/27/2000 | CA1341040C Pasteurella vaccine |
| 06/27/2000 | CA1341037C .alpha.-amidation enzyme |
| 06/23/2000 | CA2291454A1 Novel gene and method for producing l-amino acids |
| 06/23/2000 | CA2256124A1 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans |
| 06/22/2000 | WO2000036147A1 Cancer diagnosis method using cell growth inhibiting and cell differentiation specific syg972 gene and genomic dna and promoter thereof |
| 06/22/2000 | WO2000036143A2 Selecting animals for parentally imprinted traits |
| 06/22/2000 | WO2000036131A1 Synthetic nucleic acid particle |
| 06/22/2000 | WO2000036130A1 Foamy virus vectors for expressing foreign genes in mammals and the use thereof |
| 06/22/2000 | WO2000036129A1 Enhanced protein production in higher plants by n-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
| 06/22/2000 | WO2000036124A2 Plant cell cycle genes and uses thereof |
| 06/22/2000 | WO2000036123A1 Enhanced expression of heterologous proteins in recombinant bacteria through reduced growth temperature and co-expression of rare trna's |
| 06/22/2000 | WO2000036122A1 Process for producing apelin |
| 06/22/2000 | WO2000036116A2 Plant catabolite repression genes |
| 06/22/2000 | WO2000036115A2 Plant carbon catabolite repression proteins |
| 06/22/2000 | WO2000036111A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp |